Stevanato Group SpA

IT

STVN

Health Care

26.54 ₽

Current price

Buy
26.54 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    46 / 240

  • Position in country

    277 / 520

  • Return on Assets, %

    7.8

    -2.7

  • Net income margin, %

    14.1

    -6.7

  • EBITDA margin, %

    27

    5.6

  • Debt to Equity, %

    35

    15.1

  • Intangible assets and goodwill, %

    3.9

    4.7

  • Revenue CAGR 3Y, %

    17.9

    12.8

  • Total Equity change 1Y, %

    17.2

    -2.4

  • Revenue Y, % chg

    13.9

    0

  • P/E

    50.2

    32.1

  • P/BV

    6.4

    2

  • P/S

    7.6

    4.1

  • EV/S

    7.9

    3.6

  • EV/EBITDA

    29.4

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    20.7

    48.9

  • Forward P/E

    42.3

    25.5

  • Dividend Yield, %

    0.1

    0.8

  • Forward Dividend Yield, %

    0.1

    0.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    9.8

    10.1

  • Dividend Ex Date

    2023-06-07

Get an analytical review of this company

Competitors

Ranks

  • Stevanato Group SpA

    00%

  • Lonza Group AG

    00%

  • Samsung Biologics Co Ltd

    00%

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Sartorius Stedim Biotech SA

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Italy

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    8872.5

  • Ticker

    STVN.K

  • ISIN

    IT0005452658

  • IPO date

    2021-07-16

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-07

  • Date fact. publication of reports

    2023-12-31

Company Description

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.